Use of AngioVac for Removal of Tricuspid Valve Vegetation

doi:-

Contents

Abstract
Keywords

Download XML

201534 Views

18244 Downloads

Share this article

Case Report | Volume 27 Issue 1 (, 2022) | Pages 120 - 123

Use of AngioVac for Removal of Tricuspid Valve Vegetation

Peter Wallenhorst

Joshua Rutland

John Gurley

Maya Guglin

University of Kentucky, Lexington, Kentucky, USA.

University of Kentucky, Lexington, Kentucky, USA. Electronic correspondence: mguglin@gmail.com.

Under a Creative Commons license

PMID : -30560611

Published

Jan. 10, 2018

Abstract

The use is reported of the AngioVac system to resolve a case of persistent bacteremia in the setting of MRSA tricuspid valve infective endocarditis. The infection was secondary to intravenous drug use in a patient who had failed multiple antibiotic regimens and was deemed a poor surgical candidate.

How to cite: Wallenhorst, P., Rutland, J., Gurley, J., & Guglin, M. (2018). Use of AngioVac for Removal of Tricuspid Valve Vegetation. The Journal of heart valve disease, 27(1), 120–123.

Keywords

AngioVac system

Persistent bacteremia

Intravenous drug use

Antibiotic therapy

Surgical candidate

Download PDF